Virtus LifeSci Biotech Products ETF Rating $62.66 +0.45 (+0.72%) Closing price 04:10 PM EasternExtended Trading$62.70 +0.04 (+0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.79Holdings in BBP have an aggregate rating of Moderate Buy based on 683 analyst ratings issued in the past year covering 50 companies (93.0% of the portfolio).BBP Aggregate Price Target$62.66High Prediction$62.66Average Prediction$62.66Low Prediction$62.66Holdings in BBP have an aggregate price target of $62.66 and a range of $62.66 to $62.66 covering 50 companies (93.0% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy18 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.11%CRSPCRISPR Therapeutics$55.09-0.1%3.272 of 5 stars2.53$71.75 30.2%17Analyst Revision2.08%INSMInsmed$104.17-0.4%3.8445 of 5 stars3.00$108.47 4.1%17Positive NewsAnalyst ForecastInsider Trade2.03%BBIOBridgeBio Pharma$46.74-0.8%4.6446 of 5 stars3.00$61.20 30.9%15Analyst ForecastAnalyst Revision2.02%IONSIonis Pharmaceuticals$42.17-1.4%4.5472 of 5 stars2.76$57.13 35.5%171.98%KNSAKiniksa Pharmaceuticals International$28.84+1.5%3.365 of 5 stars3.00$39.33 36.4%6Upcoming EarningsInsider Trade1.98%EXELExelixis$44.87+0.1%4.78 of 5 stars2.52$45.28 0.9%21Positive NewsAnalyst Forecast1.98%ACADACADIA Pharmaceuticals$22.554.0983 of 5 stars2.71$27.88 23.6%17Analyst Revision1.97%ALNYAlnylam Pharmaceuticals$324.69+0.6%4.0353 of 5 stars2.80$346.13 6.6%25Trending NewsAnalyst ForecastAnalyst Revision1.97%ASNDAscendis Pharma A/S$177.20+1.0%3.7341 of 5 stars3.00$223.07 25.9%15Positive News1.96%MIRMMirum Pharmaceuticals$52.73-0.1%3.1293 of 5 stars3.13$65.50 24.2%81.92%LGNDLigand Pharmaceuticals$137.57+6.1%3.5323 of 5 stars3.00$147.17 7.0%6High Trading Volume1.92%NBIXNeurocrine Biosciences$134.11+0.5%4.4941 of 5 stars2.87$163.91 22.2%23Trending NewsAnalyst Revision1.92%ROIVRoivant Sciences$11.65+1.0%2.6541 of 5 stars3.25$16.50 41.6%41.91%UTHRUnited Therapeutics$297.33-0.3%4.985 of 5 stars2.69$383.08 28.8%13Positive NewsInsider Trade1.90%TBPHTheravance Biopharma$11.62-0.3%1.7183 of 5 stars2.67$16.60 42.9%6News CoverageInsider Trade1.90%TARSTarsus Pharmaceuticals$41.40-0.4%1.797 of 5 stars3.00$66.67 61.0%7News CoveragePositive NewsAnalyst Revision1.89%RYTMRhythm Pharmaceuticals$90.68-0.8%3.1825 of 5 stars3.07$91.00 0.4%15Analyst Revision1.88%REGNRegeneron Pharmaceuticals$550.00+0.4%4.8196 of 5 stars2.80$814.57 48.1%251.88%KRYSKrystal Biotech$150.15+0.0%4.5638 of 5 stars3.00$213.75 42.4%9Trending NewsInsider TradeAnalyst Revision1.88%BNTXBioNTech$111.04-1.3%1.4879 of 5 stars2.83$136.58 23.0%18Analyst Forecast1.87%ARDXArdelyx$4.52-1.7%4.1034 of 5 stars3.00$10.89 140.9%10Analyst Revision1.87%TGTXTG Therapeutics$39.19+0.9%3.4029 of 5 stars2.80$43.80 11.8%51.86%PTCTPTC Therapeutics$48.53+0.8%4.4777 of 5 stars2.67$65.00 33.9%15Analyst Revision1.86%INCYIncyte$68.94-0.4%4.6214 of 5 stars2.22$74.47 8.0%18Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.85%AGIOAgios Pharmaceuticals$40.35+0.9%4.4096 of 5 stars2.71$58.60 45.2%7Analyst Revision1.85%DAWNDay One Biopharmaceuticals$6.50-1.8%2.576 of 5 stars3.14$29.00 346.2%71.85%HALOHalozyme Therapeutics$57.81-0.3%4.8472 of 5 stars2.17$62.70 8.5%12Positive NewsAnalyst Forecast1.85%TVTXTravere Therapeutics$16.51-0.9%3.7689 of 5 stars2.87$32.14 94.7%15News CoverageAnalyst Revision1.84%VRTXVertex Pharmaceuticals$463.27-1.3%4.7373 of 5 stars2.54$511.71 10.5%28Trending NewsAnalyst ForecastAnalyst Revision1.83%HRMYHarmony Biosciences$36.43+3.5%4.8045 of 5 stars3.00$51.33 40.9%9Positive News1.83%AXSMAxsome Therapeutics$112.24+0.8%4.6937 of 5 stars3.06$172.33 53.5%16Analyst Revision1.82%AUPHAurinia Pharmaceuticals$9.07+2.5%3.1807 of 5 stars3.00$11.50 26.8%21.82%BCRXBioCryst Pharmaceuticals$8.70+1.3%4.3931 of 5 stars2.90$16.70 92.0%10Analyst Revision1.82%MDGLMadrigal Pharmaceuticals$348.73+1.1%3.7655 of 5 stars2.89$420.63 20.6%9News CoveragePositive News1.81%PHATPhathom Pharmaceuticals$8.32-0.1%4.3041 of 5 stars3.00$17.50 110.3%61.81%GILDGilead Sciences$108.80-1.0%4.896 of 5 stars2.77$111.38 2.4%26Trending NewsInsider TradeOptions VolumeAnalyst Revision1.81%BMRNBioMarin Pharmaceutical$58.370.0%4.9858 of 5 stars2.75$93.78 60.7%24News CoveragePositive NewsAnalyst Forecast1.80%DVAXDynavax Technologies$10.674.3872 of 5 stars2.50$24.00 124.9%4Positive News1.80%BIIBBiogen$128.69+0.2%4.9087 of 5 stars2.38$188.48 46.5%32Trending NewsInsider TradeAnalyst Revision1.79%RAREUltragenyx Pharmaceutical$27.41+0.4%4.4674 of 5 stars2.93$83.64 205.2%14Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume1.79%MRNAModerna$32.20+0.4%4.2898 of 5 stars2.04$46.61 44.8%25Options VolumeAnalyst Revision1.78%ONCBeOne Medicines$290.35+4.0%2.5183 of 5 stars3.00$327.56 12.8%7Analyst ForecastGap UpHigh Trading Volume1.77%FOLDAmicus Therapeutics$6.29+3.6%4.1582 of 5 stars2.80$16.22 157.9%10News CoverageAnalyst UpgradeGap Up1.75%APLSApellis Pharmaceuticals$20.04+1.5%4.3252 of 5 stars2.62$39.84 98.8%21Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.75%AMGNAmgen$298.25-0.3%4.4111 of 5 stars2.35$307.82 3.2%23Positive NewsAnalyst Revision1.74%GERNGeron$1.29+1.6%3.4578 of 5 stars2.60$4.61 257.5%101.71%LEGNLegend Biotech$42.13+6.0%3.6561 of 5 stars2.91$73.33 74.1%11News CoveragePositive NewsAnalyst ForecastGap UpHigh Trading Volume1.69%NVAXNovavax$7.00+0.6%4.349 of 5 stars2.29$17.00 142.9%71.67%IMCRImmunocore$36.21+1.3%1.3349 of 5 stars2.55$58.89 62.6%111.65%IBRXImmunityBio$2.83+2.9%2.1965 of 5 stars3.20$12.25 332.9%5 This page (NYSEARCA:BBP) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBP Stock Alerts